Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-18
    E.g., 2018-08-18

Articles

12258 items
12:40 PM, Aug 09, 2018  |  BC Extra | Financial News

Vaccinex down following $40M IPO

Vaccinex Inc. (NASDAQ:VCNX) lost $0.62 to $11.38 Thursday after it raised $40 million through the sale of 3.3 million shares at $12 in an IPO underwritten by Oppenheimer, BTIG and Ladenburg. The offering values the...
9:17 AM, Aug 09, 2018  |  BC Extra | Financial News

Novo Holdings leads Therachon's $60M round

Rare disease company Therachon AG (Basel, Switzerland) said it completed a $60 million mezzanine financing led by new investor Novo Holdings. Fellow new investors Cowen Healthcare Investments, Pfizer Ventures and funds managed by Tekla Capital Management...
1:32 PM, Aug 08, 2018  |  BC Extra | Financial News

Tot raises $102M series B

Cancer company Tot Biopharm Co. Ltd. (Suzhou, China) raised $102 million in a series B round. Participants included China Universal (Cayman) GP Ltd. and other investors as well as existing investors Center Laboratories Group, Vivo...
10:51 AM, Aug 08, 2018  |  BC Extra | Financial News

Preston joins Pivotal bioVenture

Pivotal bioVenture Partners hired Heather Preston as managing partner. She was a partner and managing director at TPG Biotech....
10:49 AM, Aug 08, 2018  |  BC Extra | Financial News

Apexigen announces $73M in series B, C rounds

Immuno-oncology company Apexigen Inc. (San Carlos, Calif.) raised a total of $73 million in its series B and C rounds. The company closed its series B round with $15 million led by Decheng Capital, while...
5:33 AM, Aug 08, 2018  |  BC Extra | Financial News

SQZ raises $72M series C

Cell therapy company SQZ Biotechnologies Co. (Watertown, Mass.) raised $72 million in an oversubscribed, untranched series C round. New investors Everblue, Illumina Ventures, Invus, Orient Life and Viva Ventures Biotech Group participated, as did existing...
4:02 AM, Aug 08, 2018  |  BC Extra | Financial News

Ambys launches with $140M from series A, Takeda deal

Liver disease company Ambys Medicines (Redwood City, Calif.) launched on Wednesday with $140 million in funding from a series A round and an option partnership with Takeda Pharmaceutical Co. Ltd. (Tokyo:4502). Ambys' $60 million series A...
8:27 PM, Aug 07, 2018  |  BC Extra | Financial News

Zogenix, Progenics raise follow-ons

Zogenix Inc. (NASDAQ:ZGNX) and Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) each priced follow-on offerings late Tuesday. Zogenix raised $312 million through the sale of 6 million shares at $52 in an offering underwritten by BofA Merrill Lynch, Leerink,...
8:06 PM, Aug 07, 2018  |  BC Extra | Financial News

BeiGene dips slightly in Hong Kong debut

BeiGene Ltd. (NASDAQ:BGNE; HKSE:6160) slipped HK$1 to HK$107 in its first day of trading on the Hong Kong exchange Wednesday. Last week, the company raised HK$7.1 billion ($902.7 million) by pricing its Hong Kong listing...
3:54 PM, Aug 07, 2018  |  BC Extra | Financial News

Sensyne proposes London IPO

Data analysis company Sensyne Health Ltd. (Oxford, U.K.) proposed to raise £60 million ($78 million) in an IPO on the London Stock Exchange's AIM market. The company expects to begin trading on Aug. 17. Sensyne uses...

Pages